Alzheimer's Research & Therapy
Affiliated with
Articles
Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
No hay comentarios:
Publicar un comentario